CEFALY Publishes the First and Largest, Phase 3 Clinical Trial of 2-hour External Trigeminal Nerve Stimulation (e-TNS) for At-Home Acute Migraine Treatment

/PRNewswire/ -- CEFALY Technology, a Belgium-based manufacturer of wearable medical devices for migraine, today announced the results of a clinical study...

Related Keywords

United States ,Belgium ,Jen Trainor Mcdermott ,Deena Kuruvilla ,Instagram ,Linkedin ,Twitter ,Cefaly Technology ,Westport Headache Institute ,Health Organization ,Facebook ,First Real World ,Sham Controlled Clinical Trial ,Hour External Trigeminal Nerve Stimulation ,Finds That ,Treating Acute Migraine ,Medical Director ,Board Certified Neurologist ,Westport Headache ,